RBC Capital analyst, Simos Simeonidis, reiterated his Outperform rating on shares of Incyte (NASDAQ: INCY) after Novartis (NYSE: NVS) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE